Impact of age on adherence and efficacy of peanut oral-immunotherapy using a standardized protocol
Pediatr Allergy Immunol
.
2021 May;32(4):783-786.
doi: 10.1111/pai.13447.
Epub 2021 Jan 25.
Authors
Rongbo Zhu
1
2
,
Kara Robertson
1
2
,
Jennifer L P Protudjer
3
4
5
6
7
,
Andrea Macikunas
2
,
Rebecca Kim
8
,
Samira Jeimy
1
2
,
Harold Kim
1
2
9
Affiliations
1
Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, ON, Canada.
2
Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
3
Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
4
George and Fay Yee Centre for Healthcare Innovation, Winnipeg, MB, Canada.
5
Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
6
Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB, Canada.
7
Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
8
Queen's University Faculty of Arts and Science, Kingston, ON, Canada.
9
Department of Medicine, McMaster University, Hamilton, ON, Canada.
PMID:
33411375
DOI:
10.1111/pai.13447
No abstract available
Publication types
Letter
MeSH terms
Administration, Oral
Allergens / therapeutic use
Arachis*
Desensitization, Immunologic
Humans
Peanut Hypersensitivity* / therapy
Substances
Allergens